Promoting Inflammation to Turn Tumors From ‘Cold’ to ‘Hot’ By Uniting TGF-β Directed Drugs & Checkpoint Inhibitors for More Effective Treatments
Time: 11:30 am
day: Conference Day One
Details:
- Exploiting the immune system by combining TGF-β targets and checkpoint inhibitors to see positive patient response
- Heating the tumor up by encouraging inflammation for a strong immune response to therapy
- Overcoming immunotherapy resistance with TGF-β targeted therapy and checkpoint inhibitors to achieve clinical success
